Table 1

Full list of data to be collected in the EVOTION clinical study

Generic data typeSpecific data typeMeans of captureRetrospectiveProspective
HASensorMobileClinic
HA loggingPeriods of HA usageXXX
Use and adjustment of HA controlsXX
TTS episode relatedPredicted TTS values due to noise exposure and time required for recoveryXXX
Time of occurrence and severity of actual TTS episodesXXXXX
Self-administered PTA at 4 kHzXX
AudiologicalPTA in quietXXX
Speech in NoiseXX
Reaction time (in Speech in Noise and Digit Span tests)XXXX
Satisfaction with HA usageXXX
PhysiologicalHeart rateXX
Respiratory rateXX
PulseXX
CognitiveCognitive assessmentXX
Digit recall test for auditory working memoryXX
Mood and QOLMood and anxiety monitoringXX
QOLXX
Clinical and medicationDiabetesXXX
ObesityXXX
Family history of HLXXX
History of medicationsXXX
Duration of HLXXX
Cause of HLXXX
Behavioural and lifestyleWatching televisionXXX
Participating in conversations and meetingsXXX
Rating of HA ease or difficulty to useXX
Socioeconomic statusXX
PersonalEducation levelXXX
Presence of significant othersXXX
AgeXXX
GenderXXX
Personal carerXXX
OccupationalEmployment history and current status (including noise exposure)XXX
EnvironmentalLocationXXX
Noise type, frequency spectrum and levelXX
Outdoor activities (eg, conversations)XXX
  • How these data will be collected (ie, automatically logged on the HA, via the wearable biosensor, the mobile phone application or at the clinic) and whether they will be collected at the retrospective (part 1) or the prospective (part 2) study is specified. Also see the ‘Study design’, ‘Prospective data collection: EVOTION HA fitting pathway’ and ‘Equipment’ sections for details.

  • HA, hearing aid; HL, hearing loss; PTA, pure tone audiometry; QOL, quality of life; TTS, temporary threshold shift.